Polyzos SA - Search Results

1

Helicobacter pylori might contribute to cancer and/or bone marrow-derived stem cell-related gastrointestinal oncogenesis.

Kountouras J, Kapetanakis N, Zavos C, Polyzos SA, Romiopoulos I, Tsiaousi E, Anastasiadou K, Giorgakis N, Vardaka E, Nikolaidou C, Venizelos I, Katsinelos P. Kountouras J, et al. Among authors: polyzos sa. Oncogene. 2015 Jan 29;34(5):670. doi: 10.1038/onc.2013.602. Epub 2014 Jan 27. Oncogene. 2015. PMID: 24469039 No abstract available.

2

Insulin resistance and therapy: cross-talk between phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways.

Polyzos SA, Kountouras J, Zavos C. Polyzos SA, et al. Med Hypotheses. 2009 May;72(5):610. doi: 10.1016/j.mehy.2008.12.019. Epub 2009 Jan 21. Med Hypotheses. 2009. PMID: 19162411 No abstract available.

3

Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines.

Polyzos SA, Kountouras J, Zavos C. Polyzos SA, et al. Curr Mol Med. 2009 Apr;9(3):299-314. doi: 10.2174/156652409787847191. Curr Mol Med. 2009. PMID: 19355912 Review.

4

The multi-hit process and the antagonistic roles of tumor necrosis factor-alpha and adiponectin in non alcoholic fatty liver disease.

Polyzos SA, Kountouras J, Zavos Ch. Polyzos SA, et al. Hippokratia. 2009 Apr;13(2):127; author reply 128. Hippokratia. 2009. PMID: 19561788 Free PMC article. No abstract available.

5

Nonlinear distribution of adiponectin in patients with nonalcoholic fatty liver disease limits its use in linear regression analysis.

Polyzos SA, Kountouras J, Zavos C. Polyzos SA, et al. J Clin Gastroenterol. 2010 Mar;44(3):229-30; author reply 230-1. doi: 10.1097/MCG.0b013e3181b5ce68. J Clin Gastroenterol. 2010. PMID: 19770674 No abstract available.

6

Adipocytokines in insulin resistance and non-alcoholic fatty liver disease: the two sides of the same coin.

Polyzos SA, Kountouras J, Zavos C, Stergiopoulos C. Polyzos SA, et al. Med Hypotheses. 2010 Jun;74(6):1089-90. doi: 10.1016/j.mehy.2009.12.028. Epub 2010 Jan 18. Med Hypotheses. 2010. PMID: 20080361 No abstract available.

7

Adiponectin as a potential therapeutic agent for nonalcoholic steatohepatitis.

Polyzos SA, Kountouras J, Zavos C. Polyzos SA, et al. Hepatol Res. 2010 Apr;40(4):446-7. doi: 10.1111/j.1872-034X.2010.00632.x. Hepatol Res. 2010. PMID: 20394676 No abstract available.

8

Zoledronic acid-induced transient hepatotoxicity in a patient effectively treated for Paget's disease of bone.

Polyzos SA, Kountouras J, Anastasilakis AD, Litsas I, Kita M, Arsos G, Moralidis E, Terpos E. Polyzos SA, et al. Osteoporos Int. 2011 Jan;22(1):363-7. doi: 10.1007/s00198-010-1230-5. Epub 2010 Apr 21. Osteoporos Int. 2011. PMID: 20407889

9

The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease.

Polyzos SA, Kountouras J, Zavos C, Tsiaousi E. Polyzos SA, et al. Diabetes Obes Metab. 2010 May;12(5):365-83. doi: 10.1111/j.1463-1326.2009.01176.x. Diabetes Obes Metab. 2010. PMID: 20415685 Review.

10

Familial prevalence of autoimmune disorders in multiple sclerosis in Northern Greece.

Deretzi G, Kountouras J, Koutlas E, Zavos C, Polyzos S, Rudolf J, Grigoriadis N, Gavalas E, Boziki M, Tsiptsios I. Deretzi G, et al. Mult Scler. 2010 Sep;16(9):1091-101. doi: 10.1177/1352458510375708. Epub 2010 Jul 16. Mult Scler. 2010. PMID: 20639270

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

460 results

Search Page

Filters